| Financial Year |
March 31 2023 |
| Monetary Funds |
215,418,269.33 |
| Held-for-trading Financial Assets |
36,983.36 |
| Notes Receivable |
-- |
| Accounts Receivable |
1,327,031,052.00 |
| Advances to Suppliers |
18,001,914.47 |
| Other Receivables |
15,590,780.02 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
378,694,183.26 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
13,158,382.24 |
| Other Current Assets |
36,645,572.84 |
| Total Current Assets |
2,191,530,283.48 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
43,632,114.88 |
| Long-term Equity Investment |
84,495,189.41 |
| Investment Properties |
20,787,105.46 |
| Fixed Assetes |
499,884,950.46 |
| Under-construction Projects |
99,468,130.24 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
628,742,809.80 |
| R&D expenses |
-- |
| Goodwill |
149,882,586.30 |
| Long-Term Deferred and Prepaid Expenses |
44,835,962.44 |
| Deferred Income Tax Assets |
48,265,936.91 |
| Other Non-Current Assets |
248,413,792.78 |
| Sub-Total of Non-Current Assets |
1,877,711,383.94 |
| Total Assets |
4,069,241,667.42 |
| Short-Term Loans |
390,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
8,453,831.20 |
| Accounts Payable |
565,462,237.49 |
| Accounts Received In Advance |
395,978.44 |
| Employee Compensation Payable |
18,884,018.88 |
| Taxes Payable |
13,859,440.78 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
11,955,578.78 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
71,167,495.19 |
| Other Current Liabilities |
73,446,333.55 |
| Sub-Total of Current Liabilities |
1,257,104,210.53 |
| Long-term Loans |
329,749,696.50 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
63,990,396.90 |
| Special Payable |
-- |
| Estimatied Liabilities |
30,911,621.97 |
| Deferred Income Tax Liabilities |
25,643,948.21 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
473,829,276.78 |
| Total Liabilities |
1,730,933,487.31 |
| Paid-In Capital(Or Share Stock) |
675,708,786.00 |
| Capital Surplus |
495,199,582.62 |
| Surplus Reserve |
93,290,141.47 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
887,929,705.74 |
| Minority Stockholder's Interest |
163,611,503.01 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,174,696,677.10 |
| Owner's Equity（Stockholder's Equity） |
2,338,308,180.11 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,069,241,667.42 |
